Clinical Trials Logo

Clinical Trial Summary

Cross-sectional observational study to improve MRI data acquisition techniques by optimising MRI sequences for multiple organs and assessing the repeatability and reproducibility of multiparametric MRI, in healthy volunteers.


Clinical Trial Description

This will be a cross-sectional, observational study recruiting up to 200 healthy participants designed at improving MRI data acquisition techniques by optimising MRI sequences and assessing different aspects of the repeatability and reproducibility of multiparametric MRI. Participants will be recruited from Perspectum's own networks, as well as through advertisements on social media platforms (e.g. Facebook, Instagram), Perspectum's website, as well as through charities. Suitable participants will be invited to attend a screening visit, normally over the telephone, which will involve collection of participant's self-reported medical evaluation to assess eligibility according to the inclusion and exclusion criteria.Visit 1 will consist of the collection of basic anthropometric measurements (e.g. height, weight, waist circumference), a medical history, and a MRI scan. Visit 2 will be a repeat of Visit 1. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05110248
Study type Observational
Source Perspectum
Contact Bryn M Horsington
Phone 01865 655343
Email bryn.horsington@perspectum.com
Status Recruiting
Phase
Start date November 15, 2021
Completion date June 15, 2024

See also
  Status Clinical Trial Phase
Terminated NCT01609816 - Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma Phase 1